Renovia Inc. is a health organization focused on discovering and delivering first-line digital therapeutic and diagnostic devices for women with pelvic floor disorders. Operating in the digital health market, Renovia serves women suffering from conditions such as urinary incontinence. The company’s business model revolves around the development and commercialization of FDA-cleared medical devices, such as their flagship product, leva, which is designed to improve pelvic floor muscle training. Renovia generates revenue through the sale of these devices and partnerships with telemedicine providers, enabling easy access to their products. The company aims to provide cost-effective care solutions, leveraging digital health technologies to enhance patient outcomes. Recent achievements include FDA 510k clearance for their next-generation pelvic digital therapeutic and recognition as a MedTech Company of the Year nominee at the New England Venture Capital 2019 NEVYs Awards.

Keywords: digital therapeutics, pelvic floor disorders, women's health, urinary incontinence, FDA-cleared, medical devices, telemedicine, cost-effective care, digital health, pelvic muscle training.